Copyright Reports & Markets. All rights reserved.

Global Targeted Radiopharmaceuticals Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Targeted Radiopharmaceuticals
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Targeted Radiopharmaceuticals Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Targeted Therapeutic Radiopharmaceuticals
    • 1.3.3 Targeted Diagnostic Radiopharmaceuticals
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Targeted Radiopharmaceuticals Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Targeted Therapy
    • 1.4.3 Targeted Diagnosis
  • 1.5 Global Targeted Radiopharmaceuticals Market Size & Forecast
    • 1.5.1 Global Targeted Radiopharmaceuticals Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Targeted Radiopharmaceuticals Sales Quantity (2018-2029)
    • 1.5.3 Global Targeted Radiopharmaceuticals Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Novartis
    • 2.1.1 Novartis Details
    • 2.1.2 Novartis Major Business
    • 2.1.3 Novartis Targeted Radiopharmaceuticals Product and Services
    • 2.1.4 Novartis Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Novartis Recent Developments/Updates
  • 2.2 Bayer
    • 2.2.1 Bayer Details
    • 2.2.2 Bayer Major Business
    • 2.2.3 Bayer Targeted Radiopharmaceuticals Product and Services
    • 2.2.4 Bayer Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Bayer Recent Developments/Updates
  • 2.3 Lantheus
    • 2.3.1 Lantheus Details
    • 2.3.2 Lantheus Major Business
    • 2.3.3 Lantheus Targeted Radiopharmaceuticals Product and Services
    • 2.3.4 Lantheus Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Lantheus Recent Developments/Updates
  • 2.4 Institute for Radioelements (IRE)
    • 2.4.1 Institute for Radioelements (IRE) Details
    • 2.4.2 Institute for Radioelements (IRE) Major Business
    • 2.4.3 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Product and Services
    • 2.4.4 Institute for Radioelements (IRE) Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Institute for Radioelements (IRE) Recent Developments/Updates
  • 2.5 Radiomedix
    • 2.5.1 Radiomedix Details
    • 2.5.2 Radiomedix Major Business
    • 2.5.3 Radiomedix Targeted Radiopharmaceuticals Product and Services
    • 2.5.4 Radiomedix Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Radiomedix Recent Developments/Updates
  • 2.6 Curium Pharma
    • 2.6.1 Curium Pharma Details
    • 2.6.2 Curium Pharma Major Business
    • 2.6.3 Curium Pharma Targeted Radiopharmaceuticals Product and Services
    • 2.6.4 Curium Pharma Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Curium Pharma Recent Developments/Updates
  • 2.7 Clarity Pharmaceuticals
    • 2.7.1 Clarity Pharmaceuticals Details
    • 2.7.2 Clarity Pharmaceuticals Major Business
    • 2.7.3 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
    • 2.7.4 Clarity Pharmaceuticals Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Clarity Pharmaceuticals Recent Developments/Updates
  • 2.8 ROTOP
    • 2.8.1 ROTOP Details
    • 2.8.2 ROTOP Major Business
    • 2.8.3 ROTOP Targeted Radiopharmaceuticals Product and Services
    • 2.8.4 ROTOP Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 ROTOP Recent Developments/Updates
  • 2.9 Ratio Therapeutics
    • 2.9.1 Ratio Therapeutics Details
    • 2.9.2 Ratio Therapeutics Major Business
    • 2.9.3 Ratio Therapeutics Targeted Radiopharmaceuticals Product and Services
    • 2.9.4 Ratio Therapeutics Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Ratio Therapeutics Recent Developments/Updates
  • 2.10 Fusion Pharmaceuticals
    • 2.10.1 Fusion Pharmaceuticals Details
    • 2.10.2 Fusion Pharmaceuticals Major Business
    • 2.10.3 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
    • 2.10.4 Fusion Pharmaceuticals Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Fusion Pharmaceuticals Recent Developments/Updates
  • 2.11 Perspective Therapeutics
    • 2.11.1 Perspective Therapeutics Details
    • 2.11.2 Perspective Therapeutics Major Business
    • 2.11.3 Perspective Therapeutics Targeted Radiopharmaceuticals Product and Services
    • 2.11.4 Perspective Therapeutics Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Perspective Therapeutics Recent Developments/Updates
  • 2.12 RayzeBio
    • 2.12.1 RayzeBio Details
    • 2.12.2 RayzeBio Major Business
    • 2.12.3 RayzeBio Targeted Radiopharmaceuticals Product and Services
    • 2.12.4 RayzeBio Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 RayzeBio Recent Developments/Updates
  • 2.13 Alpha-9 Theranostics
    • 2.13.1 Alpha-9 Theranostics Details
    • 2.13.2 Alpha-9 Theranostics Major Business
    • 2.13.3 Alpha-9 Theranostics Targeted Radiopharmaceuticals Product and Services
    • 2.13.4 Alpha-9 Theranostics Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Alpha-9 Theranostics Recent Developments/Updates
  • 2.14 Radiopharm Theranostics
    • 2.14.1 Radiopharm Theranostics Details
    • 2.14.2 Radiopharm Theranostics Major Business
    • 2.14.3 Radiopharm Theranostics Targeted Radiopharmaceuticals Product and Services
    • 2.14.4 Radiopharm Theranostics Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Radiopharm Theranostics Recent Developments/Updates
  • 2.15 Telix Pharmaceuticals
    • 2.15.1 Telix Pharmaceuticals Details
    • 2.15.2 Telix Pharmaceuticals Major Business
    • 2.15.3 Telix Pharmaceuticals Targeted Radiopharmaceuticals Product and Services
    • 2.15.4 Telix Pharmaceuticals Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Telix Pharmaceuticals Recent Developments/Updates
  • 2.16 Ariceum Therapeutics
    • 2.16.1 Ariceum Therapeutics Details
    • 2.16.2 Ariceum Therapeutics Major Business
    • 2.16.3 Ariceum Therapeutics Targeted Radiopharmaceuticals Product and Services
    • 2.16.4 Ariceum Therapeutics Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Ariceum Therapeutics Recent Developments/Updates
  • 2.17 Aktis Oncology
    • 2.17.1 Aktis Oncology Details
    • 2.17.2 Aktis Oncology Major Business
    • 2.17.3 Aktis Oncology Targeted Radiopharmaceuticals Product and Services
    • 2.17.4 Aktis Oncology Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Aktis Oncology Recent Developments/Updates
  • 2.18 Navidea Biopharmaceuticals
    • 2.18.1 Navidea Biopharmaceuticals Details
    • 2.18.2 Navidea Biopharmaceuticals Major Business
    • 2.18.3 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Product and Services
    • 2.18.4 Navidea Biopharmaceuticals Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Navidea Biopharmaceuticals Recent Developments/Updates
  • 2.19 Nucleus RadioPharma
    • 2.19.1 Nucleus RadioPharma Details
    • 2.19.2 Nucleus RadioPharma Major Business
    • 2.19.3 Nucleus RadioPharma Targeted Radiopharmaceuticals Product and Services
    • 2.19.4 Nucleus RadioPharma Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.19.5 Nucleus RadioPharma Recent Developments/Updates
  • 2.20 SmartNuclide Biopharma
    • 2.20.1 SmartNuclide Biopharma Details
    • 2.20.2 SmartNuclide Biopharma Major Business
    • 2.20.3 SmartNuclide Biopharma Targeted Radiopharmaceuticals Product and Services
    • 2.20.4 SmartNuclide Biopharma Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.20.5 SmartNuclide Biopharma Recent Developments/Updates
  • 2.21 TetraKit Technologies
    • 2.21.1 TetraKit Technologies Details
    • 2.21.2 TetraKit Technologies Major Business
    • 2.21.3 TetraKit Technologies Targeted Radiopharmaceuticals Product and Services
    • 2.21.4 TetraKit Technologies Targeted Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.21.5 TetraKit Technologies Recent Developments/Updates

3 Competitive Environment: Targeted Radiopharmaceuticals by Manufacturer

  • 3.1 Global Targeted Radiopharmaceuticals Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Targeted Radiopharmaceuticals Revenue by Manufacturer (2018-2023)
  • 3.3 Global Targeted Radiopharmaceuticals Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Targeted Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Targeted Radiopharmaceuticals Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Targeted Radiopharmaceuticals Manufacturer Market Share in 2022
  • 3.5 Targeted Radiopharmaceuticals Market: Overall Company Footprint Analysis
    • 3.5.1 Targeted Radiopharmaceuticals Market: Region Footprint
    • 3.5.2 Targeted Radiopharmaceuticals Market: Company Product Type Footprint
    • 3.5.3 Targeted Radiopharmaceuticals Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Targeted Radiopharmaceuticals Market Size by Region
    • 4.1.1 Global Targeted Radiopharmaceuticals Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Targeted Radiopharmaceuticals Consumption Value by Region (2018-2029)
    • 4.1.3 Global Targeted Radiopharmaceuticals Average Price by Region (2018-2029)
  • 4.2 North America Targeted Radiopharmaceuticals Consumption Value (2018-2029)
  • 4.3 Europe Targeted Radiopharmaceuticals Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Targeted Radiopharmaceuticals Consumption Value (2018-2029)
  • 4.5 South America Targeted Radiopharmaceuticals Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Targeted Radiopharmaceuticals Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2029)
  • 5.2 Global Targeted Radiopharmaceuticals Consumption Value by Type (2018-2029)
  • 5.3 Global Targeted Radiopharmaceuticals Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2029)
  • 6.2 Global Targeted Radiopharmaceuticals Consumption Value by Application (2018-2029)
  • 6.3 Global Targeted Radiopharmaceuticals Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2029)
  • 7.2 North America Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2029)
  • 7.3 North America Targeted Radiopharmaceuticals Market Size by Country
    • 7.3.1 North America Targeted Radiopharmaceuticals Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Targeted Radiopharmaceuticals Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2029)
  • 8.2 Europe Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2029)
  • 8.3 Europe Targeted Radiopharmaceuticals Market Size by Country
    • 8.3.1 Europe Targeted Radiopharmaceuticals Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Targeted Radiopharmaceuticals Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Targeted Radiopharmaceuticals Market Size by Region
    • 9.3.1 Asia-Pacific Targeted Radiopharmaceuticals Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Targeted Radiopharmaceuticals Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2029)
  • 10.2 South America Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2029)
  • 10.3 South America Targeted Radiopharmaceuticals Market Size by Country
    • 10.3.1 South America Targeted Radiopharmaceuticals Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Targeted Radiopharmaceuticals Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Targeted Radiopharmaceuticals Market Size by Country
    • 11.3.1 Middle East & Africa Targeted Radiopharmaceuticals Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Targeted Radiopharmaceuticals Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Targeted Radiopharmaceuticals Market Drivers
  • 12.2 Targeted Radiopharmaceuticals Market Restraints
  • 12.3 Targeted Radiopharmaceuticals Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Targeted Radiopharmaceuticals and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Targeted Radiopharmaceuticals
  • 13.3 Targeted Radiopharmaceuticals Production Process
  • 13.4 Targeted Radiopharmaceuticals Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Targeted Radiopharmaceuticals Typical Distributors
  • 14.3 Targeted Radiopharmaceuticals Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Targeted Radiopharmaceuticals market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
    Targeted radiopharmaceuticals are a type of medicinal product that combines a biologically active molecule (known as a ligand or targeting agent) with a radioactive isotope (radionuclide). These radiopharmaceuticals are designed to deliver radiation specifically to certain cells, tissues, or organs in the body, with the goal of achieving precise and localized treatment or imaging.
    The concept of targeted radiopharmaceuticals is based on the idea of using the biological specificity of the ligand to selectively bind to receptors or antigens present on the target cells. Once the ligand has bound to its target, the radioactive component emits radiation that can be used for therapeutic purposes or imaging.There are two main categories of targeted radiopharmaceuticals: targeted therapeutic radiopharmaceuticals and targeted diagnostic radiopharmaceuticals.
    Targeted radiopharmaceuticals offer several advantages over traditional treatments or imaging agents, including increased specificity, reduced damage to healthy tissues, and the potential for personalized medicine approaches based on the patient's specific disease characteristics. However, the development and use of targeted radiopharmaceuticals require careful consideration of the ligand's biological properties, radionuclide characteristics, and safety profiles to ensure effective and safe medical applications.
    The radiopharmaceuticals market had been experiencing steady growth and significant interest due to the increasing use of nuclear medicine procedures for diagnostic and therapeutic purposes. Radiopharmaceuticals are essential tools in nuclear medicine, and they play a crucial role in diagnosing various diseases, such as cancer, cardiovascular conditions, and neurological disorders.
    The radiopharmaceuticals market had been growing steadily over the years. Factors contributing to this growth include advancements in radiopharmaceutical development, rising prevalence of cancer and cardiovascular diseases, and an aging population that drives the demand for diagnostic procedures.
    The Global Info Research report includes an overview of the development of the Targeted Radiopharmaceuticals industry chain, the market status of Targeted Therapy (Targeted Therapeutic Radiopharmaceuticals, Targeted Diagnostic Radiopharmaceuticals), Targeted Diagnosis (Targeted Therapeutic Radiopharmaceuticals, Targeted Diagnostic Radiopharmaceuticals), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Targeted Radiopharmaceuticals.
    Regionally, the report analyzes the Targeted Radiopharmaceuticals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Targeted Radiopharmaceuticals market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Targeted Radiopharmaceuticals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Targeted Radiopharmaceuticals industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Targeted Therapeutic Radiopharmaceuticals, Targeted Diagnostic Radiopharmaceuticals).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Targeted Radiopharmaceuticals market.
    Regional Analysis: The report involves examining the Targeted Radiopharmaceuticals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Targeted Radiopharmaceuticals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Targeted Radiopharmaceuticals:
    Company Analysis: Report covers individual Targeted Radiopharmaceuticals manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Targeted Radiopharmaceuticals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Targeted Therapy, Targeted Diagnosis).
    Technology Analysis: Report covers specific technologies relevant to Targeted Radiopharmaceuticals. It assesses the current state, advancements, and potential future developments in Targeted Radiopharmaceuticals areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Targeted Radiopharmaceuticals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Targeted Radiopharmaceuticals market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Targeted Therapeutic Radiopharmaceuticals
    Targeted Diagnostic Radiopharmaceuticals
    Market segment by Application
    Targeted Therapy
    Targeted Diagnosis
    Major players covered
    Novartis
    Bayer
    Lantheus
    Institute for Radioelements (IRE)
    Radiomedix
    Curium Pharma
    Clarity Pharmaceuticals
    ROTOP
    Ratio Therapeutics
    Fusion Pharmaceuticals
    Perspective Therapeutics
    RayzeBio
    Alpha-9 Theranostics
    Radiopharm Theranostics
    Telix Pharmaceuticals
    Ariceum Therapeutics
    Aktis Oncology
    Navidea Biopharmaceuticals
    Nucleus RadioPharma
    SmartNuclide Biopharma
    TetraKit Technologies
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Targeted Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Targeted Radiopharmaceuticals, with price, sales, revenue and global market share of Targeted Radiopharmaceuticals from 2018 to 2023.
    Chapter 3, the Targeted Radiopharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Targeted Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Targeted Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Targeted Radiopharmaceuticals.
    Chapter 14 and 15, to describe Targeted Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion.

    Buy now